Clinical Trial Update: A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing sitamaquine to amphotericin B for visceral leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• sitamaquine (sitamaquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leishmaniasis, Visceral | Phase 2 | Status: COMPLETED